This inventor holds 2 USPTO granted patents. Top assignees: Pfizer Corporation, Warner Lambert LLC. Active years: 2005-2007.
Company Filing History:
Years Active: 2005-2007
Title: Amaya Berecibar: Innovator in Pharmaceutical Chemistry
Introduction
Amaya Berecibar is a notable inventor based in Bourg la Reine, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on substituted pyrazolo[4,3-e]diazepines. With a total of 2 patents to his name, Berecibar's inventions are paving the way for advancements in medical products.
Latest Patents
Amaya Berecibar's latest patents focus on novel substituted pyrazolo[4,3-e]diazepines and their pharmaceutical compositions. These inventions detail their use as medicinal products and the processes for preparing them. The general formula of these compounds showcases their potential in the medical field, emphasizing their importance in developing new therapeutic options.
Career Highlights
Throughout his career, Amaya Berecibar has worked with prominent companies in the pharmaceutical industry, including Warner Lambert LLC and Pfizer Corporation. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in pharmaceuticals.
Collaborations
Amaya has collaborated with several professionals in his field, including Michael Navet and Catherine Burnouf. These partnerships have fostered a collaborative environment that enhances innovation and drives progress in pharmaceutical research.
Conclusion
Amaya Berecibar's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of new medical products, showcasing the importance of innovation in healthcare.